Court rules UMCG must provide deceased son’s medical records to father after four-year battle.

Court rules UMCG acted unlawfully by withholding internal communications from father.

A Groningen father won a court case against UMCG for access to his deceased son Mike's medical records after four years of struggle.
Tom de Vries24 September 2025Last Update :
UMCG had patiëntendossier aan vader moeten geven
www.nrc.nl

A father from Groningen has won a court ruling for access to his deceased son’s medical records after a four-year battle with the University Medical Center Groningen (UMCG), one of the largest hospitals in the Netherlands.

6 Key Takeaways
  1. A Groningse father won a court case.
  2. His son Mike died in May 2021.
  3. The Universitair Medisch Centrum Groningen (UMCG) withheld medical records.
  4. Internal correspondence is part of the medical dossier.
  5. The father felt justice after four years.
  6. The UMCG is reviewing the court ruling.
Fast Answer: A father won access to his deceased son’s medical records from UMCG.

The father’s son, Mike, died in May 2021 following several complex heart surgeries. The father had been in a prolonged dispute with the hospital over access to the medical records, which his son had authorized him to view.

The court found that UMCG wrongfully denied access to the complete patient file. The hospital had also improperly allowed a researcher access to Mike’s medical data, despite the father’s objections.

“Misschien is dat voor artsen een verrassing, maar vanuit de wet is het logisch. De artsen hadden op zijn minst een aantekening moeten maken in het dossier van de patiënt dat er een uitwisseling over hem had plaatsgevonden.”

— André den Exter, gezondheidsjurist aan de Erasmus Universiteit van Rotterdam

Under Investigation: UMCG is reviewing the court ruling and has not yet provided a substantive response.

Originally reported by www.nrc.nl as “UMCG had patiëntendossier aan vader moeten geven” on 2025-09-24 11:27:00.

Leave a Comment

Your email address will not be published. Required fields are marked *


We use cookies to personalize content and ads , to provide social media features and to analyze our traffic...Learn More

Accept
Follow us on Telegram Follow us on Twitter